Adult Anaplastic Oligodendroglioma
35
0
1
19
Key Insights
Highlights
Success Rate
59% trial completion
Published Results
14 trials with published results (40%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
37.1%
13 terminated out of 35 trials
59.4%
-27.1% vs benchmark
0%
0 trials in Phase 3/4
74%
14 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (35)
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
Yoga Therapy in Treating Patients With Malignant Brain Tumors
Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
3T MRI Biomarkers of Glioma Treatment Response
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors